The invention relates to compounds of the formula I ##STR1## in which A denotes a radical of the formula II ##STR2## in which E denotes a CH.sub.2 group or an NR.sup.9 radical, G denotes a radical from the group comprising S, SO, SO.sub.2, O, CO, CS or a direct bond, B denotes an amino acid, D denotes a heterocycle and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.9 are defined in the description, and their salts. The invention in addition relates to a process for the preparation of the compounds of the formula I and their use as pharmaceuticals.
该发明涉及公式I的化合物##STR1##其中A表示公式II的基团##STR2##其中E表示一个CH.sub.2基团或一个NR.sup.9基团,G表示来自包括S、SO、SO.sub.2、O、CO、CS或直接键的基团,B表示
氨基酸,D表示杂环,并且R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6和R.sup.9在描述中有定义,以及它们的盐。此外,该发明还涉及公式I化合物的制备方法及其用作药物的用途。